Overview

Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
To determine the level of association between quantitative regional estimates of brain uptake of [18F]flutemetamol and quantitative immunohistochemical regional estimates of brain levels of amyloid estimated from post-mortem analysis of corresponding brain tissue samples.
Phase:
Phase 3
Details
Lead Sponsor:
GE Healthcare
Collaborators:
Covance
i3 Statprobe
Treatments:
Flutemetamol